Device Devices

Dxh 900 Hematology System

Payments companies reported to CMS as associated with Dxh 900 Hematology System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$75Kassociated payments (2023-2025)
194clinicians with associated payments
1company reporting

By year

2023 $9,446
2024 $12K
2025 $53K

Payments reported as associated with Dxh 900 Hematology System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Internal Medicine $51K
Emergency Medicine $15K
Anatomic Pathology & Clinical Pathology $5,410
Chemical Pathology $669
Pulmonary Disease $515
Molecular Genetic Pathology (Pathology) $351

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dxh 900 Hematology System

These are the largest totals companies reported as associated with Dxh 900 Hematology System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Shulkin Morristown, NJ Internal Medicine $50,455.32
Nima Sarani Kansas City, KS Emergency Medicine $9,844.79
Peter Farano Philadelphia, PA Anatomic Pathology & Clinical Pathology $1,583.13
Richard Hamilton Philadelphia, PA Emergency Medicine $1,425.00
Thomas Barklow Johnson City, TN Anatomic Pathology & Clinical Pathology $949.80
Mohammed Shrit Dayton, OH Anatomic Pathology & Clinical Pathology $797.78
Charles Schirmer Pinehurst, NC Chemical Pathology $668.91
Lucia Wolgast Bronx, NY Anatomic Pathology & Clinical Pathology $410.82
Cynthia Bui Astoria, NY Emergency Medicine $356.78
Doctor Goldstein Bronx, NY Molecular Genetic Pathology (Pathology) $351.47

Prescribed Dxh 900 Hematology System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.